Get 50% OFF This Monsoon!
Indraprastha Medical Corporation
No Data Available
No Stocks
Unlock Smart Score
See Detailed Analysis & Insights
Unlock Insights
See Detailed Analysis & Insights
No Research Report
ROE
Avg ROE (3 Yrs) : NaN%
ROCE
Avg ROCE (3 Yrs) : NaN%
ROA
Avg ROA (3 Yrs) : NaN%
NPM
Avg NPM (3 Yrs) : NaN%
No Data Available
Unlock Management Data
See Detailed Analysis & Insights
Indraprastha Medical Corporation was incorporated as Public Company on 16th March, 1988. The main business of the company is to enhance the quality of life of patients by providing comprehensive, high-quality hospital services on a cost-effective basis.
The company came out with the public issue of 2,29,18,300 equity shares of Rs 10 each for cash at par aggregating Rs 22,91,83,000. IMCL is setting up a multi-disciplinary super speciality teritary care referral hospital at New Delhi. The hospital was originally planned to be located within the Indira Gandhi indoor stadium complex, Mahatma Gandhi Marg, New Delhi.
In 1998-99, stroke unit to cater for strokes (Brain attack) with 4 beds has been established and a new OT complex consisting of 6 operation theatres has been commissioned. It has even set up a body mind medicine department based on ancient Eastern philosophy.
During 1999-2000, the company signed a MOU with the Governments of Tanzania and Mauritius to treat patients from these countries sponsored by their Governments. It also has tie-ups with private air transport companies to transfer critical cases.
A Puva UV therapy unit, for treatment of complex skin conditions, has been added in the dertamology department. The hospital has also installed an automated system in the microbiology unit for rapid cultures. A satellite clinic of the hospital, providing out door consultations and diagnostic facilities, was opened in Feb.'2001, in Delhi. This clinic also functions as a referral and sample collection centre for laboratory investigation.
A high energy linear accelerator was installed with multileaf collimeter enabling selective radiation to the affected part sparing normal tissue. A four digit telephone number '1066' was introduced by the Hospital for Emergency Medical Services and this is the first of its kind in the country. Three more super specialites namely Joint replacement,Spinal disorders and vascular surgeries have been started in the Hospital. The HIS is nearing completion and will be fully operational in the fag end of this financial year.
During October 2001 the Hospital opened the Satellite Clinic at Golf Link,New Delhi.
The new 57-bed Apollo Hospital in Noida offering secondary and tertiary services became operational in 2006. A specialized Clinic for Chest Pain under the banner Apollo Chest Pain Centre (ACPC)' was launched in three locations, Bansal Hospital in Friends Colony, Sehgal Nursing Home in Paschim Vihar and the Apollo Clinic in Vasant Kunj, New Delhi.
During 2009-10, Indraprastha Apollo Hospitals introduced Endoscopic Ultra Sonology (EUS), a major advancement in diagnosing and treating gastrointestinal and pancreato-biliary diseases. The Multi Organ Transplant unit of the Hospital performed 268 organ transplants in the financial year 2009-10 (117 liver and 151 kidney transplants). Significant renovation and upgradation work was completed during the year, which should add to patient comfort and help achieve more operational efficiencies. Among others, a new orthopaedics operation theatre, a 5-bed ICU for critical cardiac care patients, a 12 bed Multi Organ Transplant Unit for Renal Transplant patients, a Mezzanine in the atrium for ICU patient attendants and international patient lounge were commissioned. 58 patient rooms and 3 OPDs were also renovated.
A new Endoscopic Ultrasound Unit was commissioned in 2010-11. A Bone Marrow Transplant Unit, one of the highest end of medical services, was also created in the Hospital for intensive treatment and management of certain cancers like leukemia, lymphomas and also some non-cancerous diseases like thalessaemia. A multi organ transplant unit was added to the increasing organ transplant demands. Renovated four OPD wings and day care facility. An OP pharmacy, OPD billing counter, Insurance TPA help desk and ICU patient lobby have been setup for the comfort and ease of patients.
The expansion project undertaken by the Hospital was completed in 2011. In addition, a Cosmetic Centre was set up to provide aesthetic medicine on an out-patient basis. Out of the additional beds, 50 beds were commissioned. As part of the ongoing upgradation and renovation programme, a number of departments and units such as Gynecology & Pediatric OPD, Sample collection; Chemotherapeutics Admixture Room; Telemedicine Room; Fetal Medicine; Nucleic Acid Testing (NAT) Laboratory and Staff Cafeteria were refurbished to increase patient comfort and enhance operational efficiency. In order to meet the pressing demand of Dialysis and increased number of renal transplants, seven additional beds were commissioned in the Dialysis unit taking the capacity to 28. A new Out Patient Wing (OPD 2C) - with 14 Consultation rooms was commissioned in place of 28 general ward beds, to accommodate the new Consultants.
The Expansion Project undertaken by the main Hospital to add 127 additional Beds comprising of 74 single rooms, 33 general ward beds and 20 ICU beds, was completed. With the completion of the expansion project, the total bed strength of the Hospital has increased to 710 beds in 2012-13. The Apollo Institute of Robotic Surgery was launched in June, 2012 and has been performing a good number of robotic surgeries with the Da-Vinci Robotic Surgical System. The Hospital commissioned the Cosmetic Clinic in 2012.
In 2013-14, the Apollo Obesity and Metabolic Surgery (Bariatric surgery) Centre was commissioned. The Apollo Institute of Robotic Surgery, which was instituted last year, performed 173 surgeries during the year. The Renal Transplant services were commenced in September, 2013 and resulting to this, a total of 18 transplants were conducted in the Noida hospital during the year. The Pain Clinic was started in January 2014 offering integrated and comprehensive Pain Management for all kinds of pain. Given the rising burden of Non-Communicable Diseases and Diabetes, the Sugar Clinic was also started to help patients in better management of Diabetes and prevention of associated complications. The hospital also expanded its Emergency department with 10 additional beds being added along with a complete renovation. The total strength of the unit stands at 20 beds. Also, the Urology, Nephrology and Dermatology OP areas underwent renovation. A large number of equipments were replaced or upgraded in various specialities including Oncology, Fetal Medicine, Cosmetics, Cardiology and Microbiology along with OT and other equipment at the main hospital and in Noida.
Project Priceless, an Apollo wide initiative supported by inputs from Bain & Company, to improve overall patient experience and improve patient and physician advocacy for the Hospital, commenced in June, 2014. Plastic and Cosmetic Surgery: New Anti-aging procedures have been introduced such as Mid-face volumization; Skin lifting and tightening 'Ulthera procedure' for face, upper neck, lower neck and arms; and Cool Sculpting for non-invasive localized fat reduction for body contouring. In addition, a multitude of new investigation services have been started including Chromosomal Genetic Study, Contrast Enhanced Ultrasonography, etc. Various new Diagnostic or Surgical processes have also been added in different specialties such as Clot Evacuation in Urology, Tracheal or Bronchial Stent placement in Respiratory medicine, FET PET MRI for better imaging of brain tumours, Molecular Imaging, Nuclear Medicine, etc.
The Central Asia e-Network link was launched on 12th July 2015. The event featured a tele-consultation for a cardiac patient between doctors in Osh city in Southern Kyrgyzstan, in Bishkek and with Apollo Hospital and AIIMS. The Hospital completed a successful cadaver split liver transplant wherein both the parts of the liver were given to two adult recipients. This was the first split liver transplant in two adults reported in the city and the second in India.
Indraprastha Apollo Hospitals started providing Geriatric Services starting December 2016. New technique of Molecular Micro Film Array (Biofire) for rapid detection of micro-organisms in cases of meningitis/ encephalitis, sepsis, respiratory infections and gastroenteritis were introduced in Molecular Microbiology. In 2018-19, the Hospital commissioned a new state-of-the-art Chemotherapy Unit with 30 beds.
During 2021-22, the Bone Marrow Transplant (BMT) project Unit, created a dedicated wing for BMT unit with 8 single rooms, 3 general ward beds and 1 procedure room, which was commissioned in August 2021. Bronchoscopy and PFT lab were cohorted in one area to make it man-power optimal. A 25-bedded Dialysis Unit was created in the Lower Basement of the hospital to create a better patient experience. Orthopaedic operating theatre was moved from Ground Floor to the first floor so that all theatres are cohorted in one area. The Radiology Unit was renovated to improve patient experience.
Indraprastha Medical Corporation share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.
Market capitalization of Indraprastha Medical Corporation indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Indraprastha Medical Corporation is valued compared to its competitors.
Indraprastha Medical Corporation PE ratio helps investors understand what is the market value of each stock compared to Indraprastha Medical Corporation 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.
The PEG ratio of Indraprastha Medical Corporation evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.
Return on Equity (ROE) measures how effectively Indraprastha Medical Corporation generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.
Return on Capital Employed (ROCE) evaluates the profitability of Indraprastha Medical Corporation in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.
Total debt of Indraprastha Medical Corporation shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.
The Debt-to-Equity (DE) ratio of Indraprastha Medical Corporation compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.
CAGR shows the consistent growth rate of Indraprastha Medical Corporation over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.
Technical analysis of Indraprastha Medical Corporation helps investors get an insight into when they can enter or exit the stock. Key components of Indraprastha Medical Corporation Technical Analysis include:
There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.
There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Indraprastha Medical Corporation shares often struggle to rise above due to selling pressure.
Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Indraprastha Medical Corporation ’s financial health and profitability.
Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.
Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.
The financials of Indraprastha Medical Corporation provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.
The profit and loss statement of Indraprastha Medical Corporation highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Indraprastha Medical Corporation .
The balance sheet presents a snapshot of Indraprastha Medical Corporation ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.
Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.
Download the App